CONMED Corporation
US ˙ NYSE ˙ US2074101013

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Brian Concannon. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Brian Concannon har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CNMD / CONMED Corporation Director 10.116
US:HAE / Haemonetics Corporation President & CEO, Director 39.414
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Brian Concannon. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CNMD / CONMED Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CNMD / CONMED Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CNMD / CONMED Corporation Insider Trades
Insidersalg CNMD / CONMED Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CNMD / CONMED Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-06-07 CNMD CONCANNON BRIAN 812 129,0100 812 129,0100 104.756 323 61.9000 -54.493 -52,02
2023-05-01 CNMD CONCANNON BRIAN 2.072 125,0000 2.072 125,0000 259.000
2022-02-02 CNMD CONCANNON BRIAN 2.027 135,0900 2.027 135,0900 273.827
2022-02-02 CNMD CONCANNON BRIAN 4.200 136,9600 4.200 136,9600 575.232
2022-02-02 CNMD CONCANNON BRIAN 200 137,9100 200 137,9100 27.582
2022-02-02 CNMD CONCANNON BRIAN 2.549 135,0800 2.549 135,0800 344.319
2022-02-02 CNMD CONCANNON BRIAN 2.165 135,0800 2.165 135,0800 292.448
2022-02-02 CNMD CONCANNON BRIAN 1.843 135,0600 1.843 135,0600 248.916
2020-09-10 CNMD CONCANNON BRIAN 3.036 89,3100 3.036 89,3100 271.145

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CNMD / CONMED Corporation Insider Trades
Insiderkøb HAE / Haemonetics Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CNMD / CONMED Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HAE / Haemonetics Corporation Insider Trades
Insidersalg HAE / Haemonetics Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CNMD / CONMED Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HAE / Haemonetics Corporation Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Brian Concannon som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-04 2025-06-03 4 CNMD CONMED Corp
Common Stock
M - Exercise 479 10.116 4,97
2024-06-05 2024-05-31 4 CNMD CONMED Corp
Common Stock
M - Exercise 302 9.637 3,24
2023-06-08 2023-06-07 4 CNMD CONMED Corp
Common Stock
S - Sale -812 9.335 -8,00 129,01 -104.756 1.204.308
2023-06-02 2023-06-01 4 CNMD CONMED Corp
Common Stock
M - Exercise 335 10.147 3,41
2023-05-02 2023-05-01 4 CNMD CONMED Corp
Common Stock
S - Sale -2.072 9.812 -17,44 125,00 -259.000 1.226.500
2022-06-02 2022-06-01 4 CNMD CONMED Corp
Common Stock
M - Exercise 812 11.884 7,33
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Sars (Stock Appreciation Rights)
M - Exercise -1.000 0 -100,00
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Sars (Stock Appreciation Rights)
M - Exercise -1.000 0 -100,00
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Sars (Stock Appreciation Rights)
M - Exercise -1.000 0 -100,00
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Options To Purchase Common Stock
M - Exercise -1.843 0 -100,00
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Options To Purchase Common Stock
M - Exercise -2.165 0 -100,00
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Options To Purchase Common Stock
M - Exercise -2.549 0 -100,00
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
F - Taxes -401 11.072 -3,50 139,03 -55.751 1.539.340
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
M - Exercise 1.000 11.473 9,55 55,70 55.700 639.046
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
F - Taxes -286 10.473 -2,66 139,03 -39.763 1.456.061
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
M - Exercise 1.000 10.759 10,25 39,64 39.640 426.487
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
F - Taxes -241 9.759 -2,41 139,03 -33.506 1.356.794
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
M - Exercise 1.000 10.000 11,11 33,43 33.430 334.300
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
S - Sale -1.843 9.000 -17,00 135,06 -248.916 1.215.540
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
M - Exercise 1.843 10.843 20,48 73,94 136.271 801.731
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
S - Sale -2.165 9.000 -19,39 135,08 -292.448 1.215.720
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
M - Exercise 2.165 11.165 24,06 79,94 173.070 892.530
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
S - Sale -2.549 9.000 -22,07 135,08 -344.319 1.215.720
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
M - Exercise 2.549 11.549 28,32 69,03 175.957 797.227
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
S - Sale -200 9.000 -2,17 137,91 -27.582 1.241.190
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
S - Sale -4.200 9.200 -31,34 136,96 -575.232 1.260.032
2022-02-04 2022-02-02 4 CNMD CONMED Corp
Common Stock
S - Sale -2.027 13.400 -13,14 135,09 -273.827 1.810.206
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Options To Purchase Common Stock
A - Award 865 865
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Rsus (restricted Stock Units)
A - Award 812 812
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Rsus (restricted Stock Units)
M - Exercise -1.521 0 -100,00
2021-06-03 2021-06-01 4 CNMD CONMED Corp
Common Stock
M - Exercise 1.521 15.427 10,94
2020-09-14 2020-09-10 4 CNMD CONMED CORP
Common Stock
S - Sale -3.036 13.906 -17,92 89,31 -271.145 1.241.945
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 1.843 1.843
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1.521 1.521
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -1.407 0 -100,00
2020-06-03 2020-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 1.407 16.942 9,06
2019-06-04 2019-06-03 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 2.165 2.165
2019-06-04 2019-06-03 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1.407 1.407
2019-06-04 2019-05-31 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -1.629 0 -100,00
2019-06-04 2019-05-31 4 CNMD CONMED CORP
Common Stock
M - Exercise 1.629 15.535 11,71
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 2.549 2.549
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1.629 1.629
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -2.167 0 -100,00
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 2.167 13.906 18,46
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 3.669 3.669 51,90 190.421 190.421
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 2.167 2.167
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -2.739 0 -100,00
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 2.739 11.739 30,43
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 2.739 2.739
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 5.396 5.396
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3.000 0 -100,00
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3.000 9.000 50,00
2015-09-16 2015-09-15 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise -6.569 39.414 -14,29
2015-09-16 2015-09-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -6.569 147.040 -4,28 35,15 -230.900 5.168.456
2015-09-16 2015-09-15 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 6.569 153.609 4,47 27,69 181.896 4.253.433
2015-09-02 2015-09-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 4.761 -50,02 35,63 -169.792 169.650
2015-09-02 2015-09-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 35,63 -169.792 5.239.506
2015-09-02 2015-09-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-08-18 2015-08-17 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.569 45.983 -12,50 39,28 -258.019 1.806.134
2015-08-18 2015-08-17 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -6.569 147.040 -4,28 39,28 -258.019 5.775.481
2015-08-18 2015-08-17 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 6.569 153.609 4,47 27,68 181.863 4.252.665
2015-08-04 2015-08-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 9.526 -33,34 39,91 -190.189 380.219
2015-08-04 2015-08-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 39,91 -190.189 5.868.925
2015-08-04 2015-08-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-07-16 2015-07-15 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.569 52.552 -11,11 39,59 -260.092 2.080.733
2015-07-16 2015-07-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -6.569 147.040 -4,28 39,59 -260.092 5.821.872
2015-07-16 2015-07-15 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 6.569 153.609 4,47 27,68 181.863 4.252.665
2015-07-06 2015-07-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 14.291 -25,01 41,28 -196.711 589.968
2015-07-06 2015-07-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 41,28 -196.711 6.070.179
2015-07-06 2015-07-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-07-02 2015-06-01 4/A CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1.000 1.000
2015-07-02 2015-06-01 4/A CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3.000 3.000
2015-06-17 2015-06-15 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -6.569 59.121 -10,00 42,51 -279.221 2.512.991
2015-06-17 2015-06-15 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -6.569 147.040 -4,28 42,51 -279.221 6.250.068
2015-06-17 2015-06-15 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 6.569 153.609 4,47 27,68 181.863 4.252.665
2015-06-03 2015-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3.000 0 -100,00
2015-06-03 2015-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3.000 6.000 100,00
2015-06-02 2015-06-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 19.056 -20,00 41,39 -197.214 788.692
2015-06-02 2015-06-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 41,39 -197.214 6.085.706
2015-06-02 2015-06-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-05-04 2015-05-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 23.821 -16,67 40,74 -194.139 970.532
2015-05-04 2015-05-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 40,74 -194.139 5.990.807
2015-05-04 2015-05-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-04-02 2015-04-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 28.586 -14,29 44,51 -212.076 1.272.280
2015-04-02 2015-04-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 44,51 -212.076 6.544.324
2015-04-02 2015-04-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-03-03 2015-03-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 33.351 -12,50 44,41 -211.617 1.481.145
2015-03-03 2015-03-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 44,41 -211.617 6.530.164
2015-03-03 2015-03-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-02-03 2015-02-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 38.116 -11,11 39,15 -186.530 1.492.085
2015-02-03 2015-02-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 39,15 -186.530 5.756.013
2015-02-03 2015-02-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2015-01-06 2015-01-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 42.881 -10,00 37,20 -177.252 1.595.117
2015-01-06 2015-01-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 37,20 -177.252 5.469.697
2015-01-06 2015-01-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2014-12-03 2014-12-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 47.646 -9,09 36,72 -174.979 1.749.647
2014-12-03 2014-12-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 36,72 -174.979 5.399.573
2014-12-03 2014-12-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2014-11-04 2014-11-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.765 52.411 -8,33 35,86 -170.888 1.879.621
2014-11-04 2014-11-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.765 147.040 -3,14 35,86 -170.888 5.273.310
2014-11-04 2014-11-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.765 151.805 3,24 27,28 129.965 4.140.481
2014-10-29 2014-10-28 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -3.215 147.040 -2,14 36,22 -116.447 5.325.789
2014-10-29 2014-10-28 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -2.794 150.255 -1,83 36,22 -101.199 5.442.236
2014-10-29 2014-10-27 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -2.188 153.049 -1,41 35,92 -78.593 5.497.520
2014-10-24 2014-10-24 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -2.048 155.237 -1,30 35,44 -72.581 5.501.599
2014-10-24 2014-10-22 4 HAE HAEMONETICS CORP
Performance Shares
A - Award 53.956 103.956 107,91
2014-10-24 2014-10-22 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 119.731 119.731
2014-10-24 2014-10-22 4 HAE HAEMONETICS CORP
Common Stock
A - Award 26.978 157.285 20,70
2014-09-15 2014-09-11 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1.000 1.000
2014-09-15 2014-09-11 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3.000 3.000
2014-08-04 2014-08-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.380 0 -100,00 35,27 -154.465
2014-08-04 2014-08-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.380 130.307 -3,25 35,27 -154.465 4.595.407
2014-08-04 2014-08-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.380 134.687 3,36 25,54 111.843 3.439.233
2014-07-03 2014-07-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 4.380 -51,22 35,83 -164.798 156.916
2014-07-03 2014-07-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 35,83 -164.798 4.668.326
2014-07-03 2014-07-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2014-06-04 2014-06-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 8.980 -33,87 33,54 -154.300 301.221
2014-06-04 2014-06-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 33,54 -154.300 4.370.953
2014-06-04 2014-06-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2014-06-02 2014-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3.000 0 -100,00
2014-06-02 2014-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3.000 3.000
2014-05-05 2014-05-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 13.580 -25,30 30,01 -138.042 407.524
2014-05-05 2014-05-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 30,01 -138.042 3.910.396
2014-05-05 2014-05-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2014-04-02 2014-04-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 18.180 -20,19 32,71 -150.466 594.666
2014-04-02 2014-04-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 32,71 -150.466 4.262.329
2014-04-02 2014-04-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2014-03-04 2014-03-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 22.780 -16,80 36,36 -167.235 828.178
2014-03-04 2014-03-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 36,36 -167.235 4.737.376
2014-03-04 2014-03-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2014-02-04 2014-02-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 27.380 -14,38 37,63 -173.080 1.030.203
2014-02-04 2014-02-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 0 -100,00 37,64 -112.916
2014-02-04 2014-02-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 130.307 -2,25 37,64 -112.916 4.904.586
2014-02-04 2014-02-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 133.307 2,30 13,05 39.158 1.739.990
2014-02-04 2014-02-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 37,63 -173.080 4.902.944
2014-02-04 2014-02-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2014-01-03 2014-01-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 31.980 -12,58 41,55 -191.141 1.328.843
2014-01-03 2014-01-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 3.000 -50,00 41,63 -124.888 124.888
2014-01-03 2014-01-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 130.307 -2,25 41,63 -124.888 5.424.615
2014-01-03 2014-01-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 133.307 2,30 13,05 39.158 1.739.990
2014-01-03 2014-01-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 41,55 -191.141 5.414.556
2014-01-03 2014-01-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2013-12-03 2013-12-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 36.580 -11,17 42,29 -194.548 1.547.078
2013-12-03 2013-12-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 6.000 -33,33 42,33 -126.980 253.961
2013-12-03 2013-12-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 130.307 -2,25 42,33 -126.980 5.515.478
2013-12-03 2013-12-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 133.307 2,30 13,05 39.158 1.739.990
2013-12-03 2013-12-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 42,29 -194.548 5.511.074
2013-12-03 2013-12-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2013-11-04 2013-11-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.600 41.180 -10,05 39,96 -183.806 1.645.462
2013-11-04 2013-11-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 9.000 -25,00 39,96 -119.881 359.644
2013-11-04 2013-11-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 130.307 -2,25 39,96 -119.881 5.207.120
2013-11-04 2013-11-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 133.307 2,30 13,05 39.158 1.739.990
2013-11-04 2013-11-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -4.600 130.307 -3,41 39,96 -183.806 5.206.781
2013-11-04 2013-11-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 4.600 134.907 3,53 25,54 117.461 3.444.850
2013-10-29 2013-10-28 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -2.975 130.307 -2,23 39,55 -117.666 5.153.863
2013-10-29 2013-10-28 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -3.318 133.282 -2,43 39,55 -131.233 5.271.530
2013-10-29 2013-10-28 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -1.211 136.600 -0,88 39,55 -47.897 5.402.735
2013-10-29 2013-10-25 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -3.191 137.811 -2,26 41,09 -131.118 5.662.654
2013-10-25 2013-10-23 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 234.899 234.899
2013-10-25 2013-10-23 4 HAE HAEMONETICS CORP
Common Stock
A - Award 25.204 141.002 21,77
2013-10-02 2013-10-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 12.000 -20,00 39,88 -119.647 478.589
2013-10-02 2013-10-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 115.798 -2,53 39,88 -119.647 4.618.302
2013-10-02 2013-10-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 118.798 2,59 13,05 39.158 1.550.611
2013-09-04 2013-09-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -3.000 15.000 -16,67 39,87 -119.609 598.046
2013-09-04 2013-09-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -10.000 0 -100,00 39,87 -398.676
2013-09-04 2013-09-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 115.798 -7,95 39,87 -398.676 4.616.588
2013-09-04 2013-09-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 10.000 125.798 8,64 11,32 113.175 1.423.719
2013-09-04 2013-09-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 115.798 -2,53 39,87 -119.609 4.616.832
2013-09-04 2013-09-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 3.000 118.798 2,59 13,05 39.158 1.550.611
2013-08-05 2013-08-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -3.000 18.000 -14,29 42,30 -126.900 761.400
2013-08-05 2013-08-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00 42,23 -422.300 422.300
2013-08-05 2013-08-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 115.798 -7,95 42,22 -422.244 4.889.501
2013-08-05 2013-08-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 125.798 8,64 11,32 113.175 1.423.719
2013-08-05 2013-08-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 115.798 -2,53 42,30 -126.900 4.898.255
2013-08-05 2013-08-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 118.798 2,59 13,05 39.158 1.550.611
2013-07-30 2013-07-26 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1.000 1.000 33,43 33.430 33.430
2013-07-30 2013-07-26 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3.000 3.000
2013-07-26 2013-07-24 4 HAE HAEMONETICS CORP
Performance Shares
A - Award 50.000 50.000
2013-07-03 2013-07-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 21.000 -12,50
2013-07-03 2013-07-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 20.000 -33,33
2013-07-03 2013-07-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 115.798 -7,95 41,88 -418.820 4.849.852
2013-07-03 2013-07-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 125.798 8,64 11,32 113.175 1.423.719
2013-07-03 2013-07-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 115.798 -2,53 41,84 -125.522 4.845.046
2013-07-03 2013-07-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 118.798 2,59 13,05 39.158 1.550.611
2013-06-05 2013-06-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 24.000 -11,11
2013-06-05 2013-06-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 30.000 -25,00
2013-06-05 2013-06-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 115.798 -7,95 41,14 -411.436 4.764.347
2013-06-05 2013-06-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 125.798 8,64 11,32 113.175 1.423.719
2013-06-05 2013-06-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 115.798 -2,53 41,17 -123.519 4.767.763
2013-06-05 2013-06-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 118.798 2,59 13,05 39.158 1.550.611
2013-05-02 2013-05-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 27.000 -10,00
2013-05-02 2013-05-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 40.000 -20,00
2013-05-02 2013-05-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 115.798 -7,95 38,67 -386.742 4.478.395
2013-05-02 2013-05-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 125.798 8,64 11,32 113.175 1.423.719
2013-05-02 2013-05-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 115.798 -2,53 38,62 -115.862 4.472.200
2013-05-02 2013-05-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 118.798 2,59 13,05 39.158 1.550.611
2013-04-05 2013-04-03 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -488 115.798 -0,42 41,83 -20.413 4.843.830
2013-04-03 2013-04-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -288 0 -100,00
2013-04-03 2013-04-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 50.000 -16,67
2013-04-03 2013-04-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 116.286 -7,92 41,94 -419.393 4.876.953
2013-04-03 2013-04-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 126.286 8,60 11,32 113.175 1.429.242
2013-04-03 2013-04-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -288 116.286 -0,25 41,94 -12.079 4.876.953
2013-04-03 2013-04-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 288 116.574 0,25 26,38 7.597 3.075.222
2013-03-05 2013-03-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 288 -91,24
2013-03-05 2013-03-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 60.000 -14,29
2013-03-05 2013-03-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 116.286 -7,92 41,06 -410.624 4.774.982
2013-03-05 2013-03-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 126.286 8,60 11,32 113.175 1.429.242
2013-03-05 2013-03-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 116.286 -2,51 41,06 -123.187 4.774.982
2013-03-05 2013-03-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 119.286 2,58 26,38 79.140 3.146.765
2013-02-05 2013-02-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 3.288 -47,71
2013-02-05 2013-02-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 70.000 -12,50
2013-02-05 2013-02-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 116.286 -7,92 41,96 -419.589 4.879.233
2013-02-05 2013-02-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 126.286 8,60 11,32 113.175 1.429.242
2013-02-05 2013-02-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 116.286 -2,51 41,96 -125.877 4.879.233
2013-02-05 2013-02-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 119.286 2,58 26,38 79.140 3.146.765
2013-01-08 2013-01-07 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 6.288 -32,30
2013-01-08 2013-01-07 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 80.000 -11,11
2013-01-08 2013-01-07 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 116.286 -7,92 41,47 -414.748 4.822.939
2013-01-08 2013-01-07 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 126.286 8,60 11,32 113.175 1.429.242
2013-01-08 2013-01-07 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 116.286 -2,51 41,47 -124.424 4.822.939
2013-01-08 2013-01-07 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 119.286 2,58 26,38 79.140 3.146.765
2012-12-05 2012-12-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 9.288 -24,41
2012-12-05 2012-12-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 90.000 -10,00
2012-12-05 2012-12-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10.000 116.286 -7,92 40,75 -407.491 4.738.550
2012-12-05 2012-12-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 10.000 126.286 8,60 11,32 113.175 1.429.242
2012-12-05 2012-12-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 116.286 -2,51 40,75 -122.247 4.738.550
2012-12-05 2012-12-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 119.286 2,58 26,38 79.140 3.146.765
2012-11-05 2012-11-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.500 6.144 -19,62
2012-11-05 2012-11-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 50.000 -9,09
2012-11-05 2012-11-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -1.500 58.143 -2,51 81,82 -122.737 4.757.528
2012-11-05 2012-11-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 1.500 59.643 2,58 52,76 79.140 3.146.765
2012-11-05 2012-11-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -5.000 58.143 -7,92 81,82 -409.123 4.757.528
2012-11-05 2012-11-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 5.000 63.143 8,60 22,64 113.175 1.429.242
2012-11-02 2012-10-31 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -534 58.143 -0,91 76,33 -40.762 4.438.206
2012-11-02 2012-10-31 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -1.463 58.677 -2,43 76,33 -111.675 4.478.986
2012-10-30 2012-10-26 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -1.284 60.140 -2,09 78,51 -100.807 4.721.591
2012-10-26 2012-10-24 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 125.191 125.191
2012-10-26 2012-10-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 13.442 61.424 28,01
2012-10-25 2012-10-23 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -189 47.982 -0,39 78,04 -14.749 3.744.486
2012-10-03 2012-10-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.500 7.644 -16,40
2012-10-03 2012-10-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 55.000 -8,33
2012-10-03 2012-10-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -5.000 48.171 -9,40 80,73 -403.630 3.888.657
2012-10-03 2012-10-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 5.000 53.171 10,38 22,64 113.175 1.203.526
2012-10-03 2012-10-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -1.500 48.171 -3,02 80,73 -121.089 3.888.657
2012-10-03 2012-10-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 1.500 49.671 3,11 52,76 79.140 2.620.642
2012-09-06 2012-09-04 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.500 9.144 -14,09
2012-09-06 2012-09-04 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 60.000 -7,69
2012-09-06 2012-09-04 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -5.000 48.171 -9,40 73,67 -368.374 3.548.989
2012-09-06 2012-09-04 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 5.000 53.171 10,38 22,64 113.175 1.203.526
2012-09-06 2012-09-04 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -1.500 48.171 -3,02 73,70 -110.550 3.550.208
2012-09-06 2012-09-04 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 1.500 49.671 3,11 52,76 79.140 2.620.642
2012-08-02 2012-08-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.500 10.644 -12,35
2012-08-02 2012-08-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -5.000 65.000 -7,14
2012-08-02 2012-08-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -5.000 48.171 -9,40 71,68 -358.424 3.453.133
2012-08-02 2012-08-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 5.000 53.171 10,38 22,64 113.175 1.203.526
2012-08-02 2012-08-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -1.500 48.171 -3,02 71,92 -107.876 3.464.319
2012-08-02 2012-08-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 1.500 49.671 3,11 52,76 79.140 2.620.642
2012-07-05 2012-07-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.500 12.144 -10,99 74,01 -111.015 898.777
2012-07-05 2012-07-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 70.000 -4,11 74,02 -222.048 5.181.127
2012-07-05 2012-07-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 48.171 -5,86 74,02 -222.048 3.565.430
2012-07-05 2012-07-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 51.171 6,23 22,64 67.905 1.158.256
2012-07-05 2012-07-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -1.500 48.171 -3,02 74,01 -111.015 3.565.136
2012-07-05 2012-07-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 1.500 49.671 3,11 52,76 79.140 2.620.642
2012-06-05 2012-06-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.500 13.644 -9,90 68,59 -102.882 935.815
2012-06-05 2012-06-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 73.000 -3,95 68,47 -205.412 4.998.346
2012-06-05 2012-06-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 48.171 -5,86 68,47 -205.412 3.298.292
2012-06-05 2012-06-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 51.171 6,23 22,64 67.905 1.158.256
2012-06-05 2012-06-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -1.500 48.171 -3,02 68,59 -102.882 3.303.953
2012-06-05 2012-06-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 1.500 49.671 3,11 52,76 79.140 2.620.642
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -1.500 15.144 -9,01 71,63 -107.439 1.084.704
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.000 0 -100,00 71,79 -143.586
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 76.000 -3,80 71,71 -215.143 5.450.279
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 48.171 -5,86 71,71 -215.143 3.454.545
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 51.171 6,23 22,64 67.905 1.158.256
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -2.000 48.171 -3,99 71,79 -143.586 3.458.341
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 2.000 50.171 4,15 41,15 82.300 2.064.537
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -1.500 48.171 -3,02 71,63 -107.439 3.450.296
2012-05-03 2012-05-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 1.500 49.671 3,11 52,76 79.140 2.620.642
2012-04-09 2012-04-04 4 HAE HAEMONETICS CORP
Common Stock
D - Sale to Issuer X -167 48.171 -0,35 69,69 -11.638 3.356.984
2012-04-04 2012-04-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.000 2.000 -50,00 69,76 -139.521 139.521
2012-04-04 2012-04-02 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 79.000 -3,66 69,81 -209.426 5.514.887
2012-04-04 2012-04-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 48.338 -5,84 69,81 -209.426 3.374.413
2012-04-04 2012-04-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 51.338 6,21 22,64 67.905 1.162.036
2012-04-04 2012-04-02 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -2.000 48.338 -3,97 69,76 -139.521 3.372.083
2012-04-04 2012-04-02 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 2.000 50.338 4,14 41,15 82.300 2.071.409
2012-03-05 2012-03-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.000 4.000 -33,33 65,80 -131.600 263.200
2012-03-05 2012-03-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 82.000 -3,53 65,80 -197.400 5.395.600
2012-03-05 2012-03-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 48.338 -5,84 65,80 -197.400 3.180.640
2012-03-05 2012-03-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 51.338 6,21 22,64 67.905 1.162.036
2012-03-05 2012-03-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -2.000 48.338 -3,97 65,80 -131.600 3.180.640
2012-03-05 2012-03-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 2.000 50.338 4,14 41,15 82.300 2.071.409
2012-02-02 2012-02-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.000 6.000 -25,00 65,06 -130.120 390.360
2012-02-02 2012-02-01 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 85.000 -3,41 65,06 -195.180 5.530.100
2012-02-02 2012-02-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 48.338 -5,84 65,06 -195.180 3.144.870
2012-02-02 2012-02-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 51.338 6,21 22,64 67.905 1.162.036
2012-02-02 2012-02-01 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -2.000 48.338 -3,97 65,06 -130.120 3.144.870
2012-02-02 2012-02-01 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 2.000 50.338 4,14 41,15 82.300 2.071.409
2012-01-05 2012-01-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -2.000 8.000 -20,00 62,49 -124.976 499.902
2012-01-05 2012-01-03 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.000 88.000 -3,30 62,49 -187.463 5.498.926
2012-01-05 2012-01-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -3.000 48.338 -5,84 62,49 -187.463 3.020.535
2012-01-05 2012-01-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 3.000 51.338 6,21 22,64 67.905 1.162.036
2012-01-05 2012-01-03 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -2.000 48.338 -3,97 62,49 -124.976 3.020.535
2012-01-05 2012-01-03 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise X 2.000 50.338 4,14 41,15 82.300 2.071.409
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)